The Epoch TimesConsumers Remain in the Dark About Potential Risks of New GMO TechniquesThe Epoch TimesAgrochemical giant Monsanto announced in January that it will be using Crispr-Cas9 and its sister technology, Crispr-Cpf1, to create new crops. Cibus,… Continue reading
FierceBiotech |
Sarepta signs another Duchenne gene therapy pact as it aims for wider treatment
FierceBiotech Sarepta Therapeutics has penned its second DMD gene therapy pact this year as it announces a tie-up with France’s Genethon, a nonprofit R&D org. The research collaboration will see the Franco-American pair jointly develop treatments for Duchenne … Sarepta Therapeutics and Genethon Announce a Gene Therapy Research Collaboration for the Treatment of …Nasdaq |
|
Journal alerts readers to “technical criticism” of CRISPR study
Retraction Watch (blog) A Nature journal has posted a editor’s note to a recent letter on potential unintended consequences of CRISPR gene editing, after an executive at a company trying to commercialize the technology said the paper should be retracted. The original article … |
|
Journal alerts readers to “technical criticism” of CRISPR study …
Retraction Watch (blog) A Nature journal has posted a editor’s note to a recent letter on potential unintended consequences of CRISPR gene editing, after an executive at a company … |
|
Mayo Clinic Ventures funds new cancer-fighting cell, gene therapy
Post-Bulletin Vineti, a pioneering cell and gene therapy software and analytics company, announced Tuesday that it had completed its initial round of funding — raising $13.75 million — aimed at delivering “the first cloud-based software solution to improve patient … |